| | Identification | Back Directory |  | [Name] 
 6(R)-[2-(8(S)-Hydroxy]-2(S),6(R)-dimethyl-1,2,6,7,8,8a(R)-hexahydro-1(S)-naphthyl]ethyl-4(R)-hydroxy-3,4,5,6-tetrahydro-2H-pyran-2-one
 |  | [CAS] 
 79952-42-4
 |  | [Synonyms] 
 (4R,6R)-
 Lovastatin Lactone Diol
 Lovastatin Diol Lactone
 Simvastatin Impurity 10
 SiMvastatin Lactone Diol
 6(R)-[2-(8(S)-Hydroxy]-2(S),6(R)-dimethyl-1,2,6,7,8,8a(R)-hexahydro-1(S)-naphthyl]ethyl-4(R)-hydroxy-3,4,5,6-tetrahydro-2H-pyran-2-one
 |  | [Molecular Formula] 
 C19H28O4
 |  | [MDL Number] 
 MFCD09832923
 |  | [MOL File] 
 79952-42-4.mol
 |  | [Molecular Weight] 
 320.423
 | 
 | Chemical Properties | Back Directory |  | [Appearance] 
 Tan Solid
 |  | [Melting point ] 
 50-53°C
 |  | [Boiling point ] 
 535.7±50.0 °C(Predicted)
 |  | [density ] 
 1.17±0.1 g/cm3(Predicted)
 |  | [storage temp. ] 
 Hygroscopic, -20°C Freezer, Under Inert Atmosphere
 |  | [pka] 
 13.49±0.40(Predicted)
 | 
 | Hazard Information | Back Directory |  | [Chemical Properties] 
 Tan Solid
 |  | [Uses] 
 A Simvastatin intermediate; Lovastatin analog has the activities of decreasing blood cholesterol and low-d. lipoprotein, can be used to preparation hypolipidemic medicine.
 |  | [Definition] 
 ChEBI: A polyketide that is monacolin L bearing an additional hydroxy substituent at position 8.
 | 
 |  |